Backcross and partial advanced intercross analysis of nonobese diabetic gene-mediated effects on collagen-induced arthritis reveals an interactive effect by two major loci

Journal of Immunology

Volumn 177, Issue 6, 2006, Pages 3952-3959

  Lindqvist, Anna Karin B ^a,b   Johannesson, Martina ^a   Johansson, Åsa C M ^a   Nandakumar, Kutty S ^a   Blom, Anna M ^a   Holmdahl, Rikard ^a  

^a LUND UNIVERSITY   (Sweden)

^b Cartela AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 2; COMPLEMENT COMPONENT C5; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BACKCROSSING; COLLAGEN INDUCED ARTHRITIS; COMPLEMENT BLOOD LEVEL; COMPLEMENT DEFICIENCY; CONGENIC STRAIN; CONTROLLED STUDY; DISEASE SEVERITY; FLOW CYTOMETRY; GENE; GENE LOCUS; GENE SEGREGATION; GENOTYPE; INCIDENCE; LINKAGE ANALYSIS; MACROPHAGE; MOUSE; NONHUMAN; NONOBESE DIABETIC GENE; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 33748567828     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.6.3952     Document Type: Article

References (39)

1. Glazier, A. M., J. H. Nadeau, and T. J. Aitman. 2002. Finding genes that underlie complex traits. Science 298: 2345-2349.
2. MacGregor, A. J., H. Snieder, A. S. Rigby, M. Koskenvuo, J. Kaprio, K. Aho, and A. J. Silman. 2000. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43: 30-37.
3. Cornelis, F., S. Faure, M. Martinez, J. F. Prud'homme, P. Fritz, C. Dib, H. Alves, P. Barrera, N. de Vries, A. Balsa, et al. 1998. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. USA 95: 10746-10750.
4. MacKay, K., S. Eyre, A. Myerscough, A. Milicic, A. Barton, S. Laval, J. Barrett, D. Lee, S. White, S. John, et al. 2002. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46: 632-639.
5. Lindqvist, A. K., R. Bockermann, Å. C. Johansson, K. S. Nandakumar, M. Johannesson, and R. Holmdahl. 2002. Mouse models for rheumatoid arthritis. Trends Genet. 18: 7-13.
6. Holmdahl, R., M. Andersson, T. J. Goldschmidt, K. Gustafsson, L. Jansson, and J. A. Mo. 1990. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol. Rev. 118: 193-232.
7. Brunsberg, U., K. Gustafsson, L. Jansson, E. Michaëlsson, L. Åhrlund-Richter, S. Pettersson, R. Mattsson, and R. Holmdahl. 1994. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur. J. Immunol. 24: 1698-1702.
8. Hultqvist, M., P. Olofsson, J. Holmberg, B. T. Bäckström, J. Tordsson, and R. Holmdahl. 2004. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. USA 101: 12646-12651.
9. Olofsson, P., J. Holmberg, J. Tordsson, S. Lu, B. Åkerström, and R. Holmdahl. 2003. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat. Genet. 33: 25-32.
10. Nadeau, J. H. 2001. Modifier genes in mice and humans. Nat. Rev. Genet. 2: 165-174.
11. Johannesson, M., J. Karlsson, P. Wernhoff, K. S. Nandakumar, A. K. Lindqvist, L. Olsson, A. D. Cook, A. Andersson, and R. Holmdahl. 2005. Identification of epistasis through a partial advanced intercross reveals three arthritis loci within the Cia5 QTL in mice. Genes Immun. 6: 175-185.
12. + T cell ratio. J. Immunol. 174: 533-541.
13. Johansson, Å. C. M., M. Sundler, P. Kjellen, M. Johannesson, A. Cook, A. K. Lindqvist, B. Nakken, A. I. Bolstad, R. Jonsson, M. Alarcon-Riquelme, and R. Holmdahl. 2001. Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcγRIIb and is not associated with loci controlling diabetes. Eur. J. Immunol. 31: 1847-1856.
14. Spinella, D. G., J. R. Jeffers, R. A. Reife, and J. M. Stuart. 1991. The role of C5 and T-cell receptor Vb genes in susceptibility to collagen induced arthritis. Immunogenetics 34: 23-27.
15. Mori, L., and G. de Libero. 1998. Genetic control of susceptibility to collagen-induced arthritis in T cell receptor β-chain transgenic mice. Arthritis Rheum. 41: 256-262.
16. Ji, H., D. Gauguier, K. Ohmura, A. Gonzalez, V. Duchatelle, P. Danoy, H. J. Garchon, C. Degott, M. Lathrop, C. Benoist, and D. Mathis. 2001. Genetic influences on the end-stage effector phase of arthritis. J. Exp. Med. 194: 321-330.
17. Baxter, A. G., and A. Cooke. 1993. Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 42: 1574-1578.
18. Wetsel, R. A., D. T. Fleischer, and D. L. Haviland. 1990. Deficiency of the murine fifth complement component (C5): a 2-base pair gene deletion in a 5′-exon. J. Biol. Chem. 265: 2435-2440.
19. Gerard, C., and N. P. Gerard. 1994. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12: 775-808.
20. Boackle, S. A. 2003. Complement and autoimmunity. Biomed. Pharmacother. 57: 269-273.
21. Banda, N. K., D. Kraus, A. Vondracek, L. H. Huynh, A. Bendele, V. M. Holers, and W. P. Arend. 2002. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. Arthritis Rheum. 46: 3065-3075.
22. Grant, E. P., D. Picarella, T. Burwell, T. Delaney, A. Croci, N. Avitahl, A. A. Humbles, J. C. Gutierrez-Ramos, M. Briskin, C. Gerard, and A. J. Coyle. 2002. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J. Exp. Med. 196: 1461-1471.
23. Wang, Y., J. Kristan, L. Hao, C. S. Lenkoski, Y. Shen, and L. A. Matis. 2000. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J. Immunol. 164: 4340-4347.
24. Wang, Y., S. A. Rollins, J. A. Madri, and L. A. Matis. 1995. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. USA 92: 8955-8959.
25. Wakeland, E., L. Morel, K. Achey, M. Yui, and J. Longmate. 1997. Speed congenics: a classic technique in the fast line (relatively speaking). Immunol. Today 18: 472-477.
26. Truett, G. E., P. Heeger, R. L. Mynatt, A. A. Truett, J. A. Walker, and M. L. Warman. 2000. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). BioTechniques 29: 52, 54.
27. Holmdahl, R., S. Carlsen, A. Mikulowska, M. Vestberg, U. Brunsberg, A.-S. Hansson, M. Sundvall, L. Jansson, and U. Pettersson. 1998. Genetic analysis of murine models for rheumatoid arthritis. In Human Genome Methods. K. W. Adolpho, ed. CRC press. New York. pp. 215-238.
28. Holmdahl, R., L. Klareskog, M. Andersson, and C. Hansen. 1986. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics 24: 84-89.
29. Andersson, M., T. J. Goldschmidt, E. Michaëlsson, A. Larsson, and R. Holmdahl. 1991. T cell receptor Vβ haplotype and complement C5 play no significant role for the resistance to collagen induced arthritis in the SWR mouse. Immunology 73: 191-196.
30. Broman, K. W., H. Wu, S. Sen, and G. A. Churchill. 2003. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
31. Sen, S., and G. A. Churchill. 2001. A statistical framework for quantitative trait mapping. Genetics 159: 371-387.
32. Churchill, G. A., and R. W. Doerge. 1994. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971.
33. Wicker, L. S., G. Chamberlain, K. Hunter, D. Rainbow, S. Howlett, P. Tiffen, J. Clark, A. Gonzalez-Munoz, A. M. Cumiskey, R. L. Rosa, et al. 2004. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J. Immunol. 173: 164-173.
34. Wandstrat, A. E., C. Nguyen, N. Limaye, A. Y. Chan, S. Subramanian, X. H. Tian, Y. S. Yim, A. Pertsemlidis, H. R. Garner, Jr., L. Morel, and E. K. Wakeland. 2004. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21: 769-780.
35. Kemp, P. A., J. H. Spragg, J. C. Brown, B. P. Morgan, C. A. Gunn, and P. W. Taylor. 1992. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies. J. Clin. Lab. Immunol. 37: 147-162.
36. Hogasen, K., T. E. Mollnes, M. Harboe, O. Gotze, H. B. Hammer, and M. Oppermann. 1995. Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid. J. Rheumatol. 22: 24-28.
37. Hietala, M. A., K. S. Nandakumar, L. Persson, S. Fahlen, R. Holmdahl, and M. Pekna. 2004. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur. J. Immunol. 34: 1208-1216.
38. Woodruff, T. M., A. J. Strachan, N. Dryburgh, I. A. Shiels, R. C. Reid, D. P. Fairlie, and S. M. Taylor. 2002. Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat. Arthritis Rheum. 46: 2476-2485.
39. Williams, A. S., M. Mizuno, P. J. Richards, D. S. Holt, and B. P. Morgan. 2004. Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis. Arthritis Rheum. 50: 3035-3044.